Canadian study 'will change heart surgery'

A massive Canadian study that caused a popular heart surgery drug to be pulled from the shelves last November has shown it increased the risk of death by 50 per cent over two rival medications.

Please complete all fields marked below with * .
*Issue:
*Your Name:
*E-mail:
Phone:

Thank you for taking time to write. Please provide enough information for us to find and address your concern. If reporting a typo, please include the misspelled word. If you are reporting a mistake in the newspaper, please include the headline and page number:

*Details:
Thank you for writing us. We will try to address every report sent to thestar.com and regret we can not respond to submissions in person. Personal information requested above is for verification process only and won't appear on thestar.com without your consent. Read our privacy policy.